Flurbiprofen-loaded nanoparticles prepared with polyvinylpyrrolidone using Shirasu porous glass membranes and a spray-drying technique: Nano-sized formation and improved bioavailability

Journal of Microencapsulation

Volumn 30, Issue 7, 2013, Pages 674-680

  Oh, Dong Hoon ^a   Din, Fakhar Ud ^b   Kim, Dong Wuk ^b   Kim, Jong Oh ^a   Yong, Chul Soon ^a   Choi, Han Gon ^b  

^a Yeungnam University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

Flurbiprofen; Nanoparticle; Polyvinylpyrrolidone; Shirasu porous glass membrane; Spray drying

Indexed keywords

CARBOXYMETHYLCELLULOSE; DRUG CARRIER; FLUBEN; FLURBIPROFEN; NANOPARTICLE; PARACETAMOL; POLOXAMER; POVIDONE; SURFACTANT; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM COMPARISON; DRUG SOLUBILITY; DRUG STABILITY; EMULSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT SCATTERING; MALE; NANOEMULSION; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; POWDER; RAT; SCANNING ELECTRON MICROSCOPE; SHIRASU POROUS GLASS MEMBRANE EMULSIFICATION TECHNIQUE; SPRAY DRYING;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DESICCATION; DRUG CARRIERS; EMULSIONS; FLURBIPROFEN; MALE; NANOPARTICLES; PARTICLE SIZE; POROSITY; POVIDONE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84885359079     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2013.774447     Document Type: Article

References (24)

1. Baek HH, Kwon SY, Rho SJ, Lee JH, Yang HJ, Hah JM, Kim YR, Yong CS, Choi HG. Enhanced solubility and bioavailability of flurbiprofen by cycloamylose. Arch Pharm Res, 2012;35(4):683-9.
2. Balakrishnan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP, Kim JA, Yoo BK, Woo JS, Yong CS, et al. Enhanced oral bioavailability of dexibuprofen by a novel solid SEDDS formulation. Eur J Pharm Biopharm, 2009;72: 539-45.
3. Choi HG, Oh YK, Kim CK. In-situ gelling and mucoadhesive liquid suppository containing acetaminophen: Enhanced bioavailability. Int J Pharm, 1998;165:23-32.
4. Davies NM. Clinical pharmacokinetics of flurbiprofen and its enantiomers. Clin Pharmacokinet, 1995;28:100-14.
5. Grau MJ, Kayser O, Müller RH. Nanosuspensions of poorly soluble drugs-Reproducibility of small scale production. Int J Pharm, 2000;196:155-7.
6. Gupta GD, Jain S, Jain NK. Formulation of an aqueous injection of flurbi-profen. Pharmazie, 1997;52:709-12.
7. Habib MJ, Phan MT, Owusu-Ababio G. Dissolution profiles of flurbiprofen in phospholipid solid dispersions. Drug Dev Ind Pharm, 1998;24: 1077-82.
8. Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci, 1997;86:1-12.
9. Joe JH, Lee WM, Park YJ, Joe KH, Oh DH, Seo YG, Woo JS, Yong CS, Choi HG. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Int J Pharm, 2010;395:161-6.
10. Kim DW, Kang JH, Oh DH, Yang CS, Choi HG. Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier. J Microencapsul, 2012;29(4):323-30.
11. Kim CK, Yoon YS. Preparation and evaluation of flurbiprofen dry elixir as a novel dosage form using a spray drying technique. Int J Pharm, 1995;120:21-31.
12. Li DX, Han MJ, Balakrishnan P, Yan YD, Oh DH, Joe JH, Seo Y, Kim JO, Park SM, Yong CS, et al. Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound. Arch Pharm Res, 2010a;33:95-101.
13. Li DX, Oh YK, Lim SJ, Kim JO, Yang HJ, Sung JH, Yong CS, Choi HG. Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray drying technique. Int J Pharm, 2008;355:277-84.
14. Li DX, Yan YD, Oh DH, Yang KY, Seo YG, Kim JO, Kim YI, Yong CS, Choi HG. Development of valsartan-loaded gelatin microcapsule without crystal change using hydroxypropylmethylcellulose as a stabilizer. Drug Deliv, 2010b;17:322-9.
15. Newa M, Bhandari KH, Li DX, Kim JO, Yoo DS, Kim JA, Yoo BK, Woo JS, Lyoo WS, Yong CS, et al. Preparation and evaluation of immediate release ibuprofen solid dispersions using polyethylene glycol 4000. Biol Pharm Bull, 2008;31:939-45.
16. Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc, 1897;19:930-4.
17. Oh DH, Balakrishnan P, Oh YK, Kim DD, Yong CS, Choi HG. Effect of process parameters on nanoemulsion droplet size and distribution in SPG membrane emulsification. Int J Pharm, 2011;404:191-7.
18. Park KM, Gao ZG, Kim CK. Assay of flurbiprofen in rat plasma using HPLC with fluorescence detection. J Liq Chrom Rel Technol, 1997;20:1849-55.
19. Park KM, Lee MK, Hwang KJ, Kim CK. Phospholipid-based microemul-sions of flurbiprofen by the spontaneous emulsification process. Int J Pharm, 1999;183:145-54
20. Society of Toxicology (SOT). Guiding principles in the use of animals in toxicology [online]. Available at: www.toxicology.org/AI/FA/guiding-principles. pdf. Accessed December 2008.
21. Yang W, Peters JI, Williams RO 3rd. Inhaled nanoparticles-a current review. Int J Pharm, 2008;356:239-47.
22. Yan YD, Sung JH, Kim KK, Kim DW, Kim JO, Lee BJ, Yong CS, Choi HG. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Int J Pharm, 2012;422:202-10.
23. Yong CS, Li DX, Oh DH, Kim JA, Yoo BK, Woo JS, Rhee JD, Choi HG. Retarded dissolution of ibuprofen in gelatin microcapsule by cross-linking with glutaradehyde. Arch Pharm Res, 2005;29:431-534.
24. Yuasa H, Takahashi H, Ozeki T, Kanaya Y, Ueno M. Application of the solid dispersion method to the controlled release of medicine. III. Control of the release of slightly water soluble medicine from solid dispersion granules. Chem Pharm Bull, 1993;41:397-9.